Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Robert D Arbeit"'
Autor:
Maryam A Amour, Christiaan A Rees, Patricia J Munseri, Jamila Said, Albert K Magohe, Mecky Matee, Elizabeth A Talbot, Robert D Arbeit, Kisali Pallangyo, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0268685 (2022)
BackgroundProspective studies of interferon-gamma release assays (IGRA) on healthy subjects in tuberculosis-endemic regions have not examined the long-term variability of serial assays. This issue is relevant to the interpretation of tuberculosis (TB
Externí odkaz:
https://doaj.org/article/ec5b57f47c29471eb2f98340c7c19c07
Autor:
Tereza Masonou, David A Hokey, Timothy Lahey, Alice Halliday, Luis C Berrocal-Almanza, Wendy F Wieland-Alter, Robert D Arbeit, Ajit Lalvani, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217091 (2019)
BACKGROUND:DAR-901 is an inactivated whole cell tuberculosis booster vaccine, prepared using a new scalable, broth-grown method from the master cell bank of SRL172, a vaccine previously shown to prevent tuberculosis. This study examined whether DAR-9
Externí odkaz:
https://doaj.org/article/88ddceddb42140d889ed399b458a473e
Autor:
C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, Bernard Landry, Leway Kailani, Lisa V Adams, Brenda C Haynes, Todd Mackenzie, Wendy Wieland-Alter, Ruth I Connor, Sue Tvaroha, David A Hokey, Ann M Ginsberg, Richard Waddell
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175215 (2017)
Development of a tuberculosis vaccine to boost BCG is a major international health priority. SRL172, an inactivated whole cell booster derived from a non-tuberculous mycobacterium, is the only new vaccine against tuberculosis to have demonstrated eff
Externí odkaz:
https://doaj.org/article/72ed7a4d28b543bb9c08543d05916f7e
Autor:
Timothy Lahey, Dominick Laddy, Krystal Hill, Jacqueline Schaeffer, Alison Hogg, James Keeble, Belinda Dagg, Mei Mei Ho, Robert D Arbeit, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168521 (2016)
BACKGROUND:The development of a novel tuberculosis vaccine is a leading global health priority. SRL172, an inactivated, whole-cell mycobacterial vaccine, was safe, immunogenic and reduced the incidence of culture-confirmed tuberculosis in a phase III
Externí odkaz:
https://doaj.org/article/752dbd23edf44389a36256452cb80ba1
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83731 (2013)
Campylobacter infection is a leading cause of bacterial gastroenteritis worldwide, and most clinical cases appear as isolated, sporadic infections for which the source is rarely apparent. From July 2005 to December 2007 we conducted a prospective cas
Externí odkaz:
https://doaj.org/article/dac08638582243c5a04fa4771a80af87
Autor:
Timothy Lahey, Brian K Mitchell, Robert D Arbeit, Siddharth Sheth, Mecky Matee, C Robert Horsburgh, Todd MacKenzie, Lillian Mtei, Muhammad Bakari, Jenni M Vuola, Kisali Pallangyo, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22074 (2011)
Surrogate immunologic markers for natural and vaccine-mediated protection against tuberculosis (TB) have not been identified.HIV-infected adults with childhood BCG immunization entering the placebo arm of the DarDar TB vaccine trial in Dar es Salaam,
Externí odkaz:
https://doaj.org/article/d2915e0deb0d4b61a1c40f6107a55465
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16167 (2011)
Multi-locus sequence typing (MLST) has emerged as the state-of-the-art method for resolving bacterial population genetics but it is expensive and time consuming. We evaluated the potential of high resolution melting (HRM) to identify known MLST allel
Externí odkaz:
https://doaj.org/article/4e76e0b315fb4cf3a2fe54afe245adda
Autor:
Robert H.I. Andtbacka, Yan Wang, Robert H. Pierce, Jean S. Campbell, Melinda Yushak, Mohammed Milhem, Merrick Ross, Katie Niland, Robert D. Arbeit, Sudha Parasuraman, Kris Bickley, Cecilia CS Yeung, Lauri D. Aicher, Kimberly S. Smythe, Lu Gan
Publikováno v:
Cancer Research Communications. 2:904-913
Purpose: Mavorixafor is an oral, selective inhibitor of the CXCR4 chemokine receptor that modulates immune cell trafficking. A biomarker-driven phase Ib study (NCT02823405) was conducted in 16 patients with melanoma to investigate the hypothesis that
Autor:
Lu Gan, Kimberly S. Smythe, Lauri D. Aicher, Cecilia CS Yeung, Kris Bickley, Sudha Parasuraman, Robert D. Arbeit, Katie Niland, Merrick Ross, Mohammed Milhem, Melinda Yushak, Jean S. Campbell, Robert H. Pierce, Yan Wang, Robert H.I. Andtbacka
Antibody panels used for mIF analyses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2a1af716f0bd76c6e9fa7b043dbd23
https://doi.org/10.1158/2767-9764.22545773.v1
https://doi.org/10.1158/2767-9764.22545773.v1
Autor:
Lu Gan, Kimberly S. Smythe, Lauri D. Aicher, Cecilia CS Yeung, Kris Bickley, Sudha Parasuraman, Robert D. Arbeit, Katie Niland, Merrick Ross, Mohammed Milhem, Melinda Yushak, Jean S. Campbell, Robert H. Pierce, Yan Wang, Robert H.I. Andtbacka
Serum cytokine and chemokine changes at the end of the 3-week monotherapy period compared to baseline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c5098d1822b7b01f14f78eb4c3a72ba
https://doi.org/10.1158/2767-9764.22545770.v1
https://doi.org/10.1158/2767-9764.22545770.v1